Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
126 GBX | +1.61% | +1.61% | +2.11% |
Apr. 11 | Syncona agrees to sell stake in investee company for GBP7.4 million | AN |
Apr. 11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
Sales 2022 | 18.69M 23.25M | Sales 2023 | -39.79M -49.49M | Capitalization | 992M 1.23B |
---|---|---|---|---|---|
Net income 2022 | 8M 9.95M | Net income 2023 | -56M -69.64M | EV / Sales 2022 | 57.1 x |
Net cash position 2022 | 276K 343K | Net cash position 2023 | 11K 13.68K | EV / Sales 2023 | -24.9 x |
P/E ratio 2022 |
122
x | P/E ratio 2023 |
-17.7
x | Employees | 1,208 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.83% |
Latest transcript on Syncona Limited
1 day | +1.21% | ||
1 week | +0.31% | ||
Current month | +1.13% | ||
1 month | +0.97% | ||
3 months | +8.54% | ||
6 months | -0.81% | ||
Current year | +0.80% |
Managers | Title | Age | Since |
---|---|---|---|
Annabel Clark
IRC | Investor Relations Contact | - | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 22-01-31 | |
Virginia Holmes
BRD | Director/Board Member | 64 | 20-12-31 |
Kemal Malik
BRD | Director/Board Member | 61 | 20-06-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 126 | +1.61% | 1 149 049 |
24-04-23 | 124 | 0.00% | 837,331 |
24-04-22 | 124 | +2.14% | 377,097 |
24-04-19 | 121.4 | -1.62% | 212,338 |
24-04-18 | 123.4 | -0.48% | 157,297 |
Delayed Quote London S.E., April 24, 2024 at 03:44 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+0.80% | 1.01B | |
+15.64% | 75.88B | |
+49.15% | 16.82B | |
+7.78% | 16.73B | |
+7.94% | 14.27B | |
+0.78% | 12.65B | |
+9.84% | 12.08B | |
+7.43% | 10.83B | |
+33.33% | 10.31B | |
-1.01% | 9.77B |
- Stock Market
- Equities
- BACT Stock